{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:27:15Z","timestamp":1791116835478,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.neuropharm.2013.10.009","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T22:20:13Z","timestamp":1382566813000},"page":"350-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Loss of PINK1 enhances neurodegeneration in a mouse model of\u00a0Parkinson's disease triggered by mitochondrial stress"],"prefix":"10.1016","volume":"77","author":[{"given":"Nicoleta","family":"Moisoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Miguel","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.10.009_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007559","article-title":"Quality control of mitochondrial proteostasis","author":"Baker","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib3","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib4","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399410001456","article-title":"Mitochondrial quality control and neurological disease: an emerging connection","volume":"12","author":"de Castro","year":"2010","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/cdd.2012.5","article-title":"Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster","volume":"19","author":"de Castro","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/emmm.200900024","article-title":"PINK1 function in health and disease","volume":"1","author":"Deas","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib7","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.expneurol.2012.01.002","article-title":"Pink1-deficiency in mice impairs gait olfaction and serotonergic innervation of the olfactory bulb","volume":"235","author":"Glasl","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib10","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1242\/jcs.075119","article-title":"The mitochondrial UPR-protecting organelle protein homeostasis","volume":"123","author":"Haynes","year":"2010","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tips.2011.06.001","article-title":"Genetic mutations and functions of PINK1","volume":"32","author":"Kawajiri","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib12","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.1073\/pnas.0702717104","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice","volume":"104","author":"Kitada","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/WCO.0b013e3283547627","article-title":"Genetics of Parkinson disease and other movement disorders","volume":"25","author":"Kumar","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-94-007-2869-1_12","article-title":"Mitochondria in neurodegeneration","volume":"942","author":"Lezi","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib15","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1242\/jcs.115.11.2367","article-title":"Calmodulin-containing substructures of the centrosomal matrix released by microtubule perturbation","volume":"115","author":"Moisoi","year":"2002","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/cdd.2008.166","article-title":"Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response","volume":"16","author":"Moisoi","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/emmm.200900006","article-title":"Parkinson's disease mutations in PINK1 result in decreased complex 1 activity and deficient synaptic function","volume":"1","author":"Morais","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1526-968X(200011\/12)28:3\/4<147::AID-GENE90>3.0.CO;2-G","article-title":"Z\/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision","volume":"28","author":"Novak","year":"2000","journal-title":"Genesis"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update","volume":"31","author":"Nuytemans","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00401-011-0902-3","article-title":"Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease","volume":"123","author":"Pilsl","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib22","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/emboj.2012.38","article-title":"Mitochondrial quality control: a matter of life and death for neurons","volume":"31","author":"Rugarli","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib23","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1523\/JNEUROSCI.0760-05.2005","article-title":"Bcl-x is required for proper development of the mouse substantia nigra","volume":"25","author":"Savitt","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analysing real time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1a contributes to neurodegeneration in Parkinson's disease","volume":"144","author":"Shin","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson's disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2013.10.009_bib27","first-page":"S65","article-title":"Non motor manifestations of Parkinson's disease","volume":"64","author":"Simuni","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2012.06.035","article-title":"The search for the genetic mouse models of prodromal Parkinson's disease","volume":"237","author":"Smith","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib29","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.1103295108","article-title":"Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in\u00a0vivo","volume":"108","author":"Sterky","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.emboj.7601972","article-title":"Quality control of mitochondria: protection against neurodegeneration and aging","volume":"27","author":"Tatsuta","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib31","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.biocel.2009.02.018","article-title":"The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics","volume":"41","author":"Thomas","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","article-title":"Fission and selective fusion govern mitochondrial segregation and elimination by autophagy","volume":"27","author":"Twig","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bbabio.2008.05.001","article-title":"Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view","volume":"1777","author":"Twig","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/ddq531","article-title":"Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization","volume":"20","author":"Van Laar","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/auto.7.3.14502","article-title":"Mitochondria removal by autophagy","volume":"7","author":"Wang","year":"2011","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.neuropharm.2013.10.009_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002455","article-title":"PINK1 is necessary for long-term survival and mitochondrial function in human dopaminergic neurons","volume":"3","author":"Wood-Kaczmar","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2013.10.009_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm3028","article-title":"Mechanisms of mitophagy","volume":"12","author":"Youle","year":"2011","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2013.10.009_bib39","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1093\/emboj\/cdf445","article-title":"A\u00a0mitochondrial specific stress response in mammalian cells","volume":"21","author":"Zhao","year":"2002","journal-title":"EMBO J."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813004838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813004838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:39:56Z","timestamp":1646908796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813004838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":39,"alternative-id":["S0028390813004838"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of PINK1 enhances neurodegeneration in a mouse model of\u00a0Parkinson's disease triggered by mitochondrial stress","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}